Karyopharm Therapeutics Inc. - 8-K Filing
Karyopharm Therapeutics entered a Forbearance Agreement with lenders and noteholders to address defaults on $15.8M loan payment, unpaid interest obligations, and liquidity covenant risks. (Items: 1.01 Entry into a Material Definitive Agreement, 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, 3.02 Unregistered Sales of Equity Securities, 8.01 Other Events)
Tickers: $KPTI